← Leaderboards
Chad Shenk
Pennsylvania State University, The
$1,536,291
Attributed
$1,536,291
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $427.4K · FY2018–22$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,536,291 · 2
By mechanism
R01$1,375,791 · 1
R03$160,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Pennsylvania State University, The
Same institution · by research overlap
- Sarah Font$3,133,536
- Hannah Milena Caroline Schreier$6,883,213
- Mingfu Shao$1,848,131
- Corina Graif$691,831
- Donna Lynn Coffman$2,731,669
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposDesignCohortVariantProspectiveChildhoodExposure ToEnrollmentProspective Cohort StudySiteReproducibilityPublic HealthAdolescencePerformanceChildAdultCellsBlood SpecimenBiological ModelsCognitive Aging16 Year OldData CollectionCognitive AbilityCognitive
Grant awards (6)
Improving Risk Estimation in Observational Research on Child Maltreatment: Establishing Methods for the Effective Control of Contamination$80,250
R03 · FY2022 · HD · contact PI
Epigenetic Age Acceleration as a Biomarker of Early Life Adversity and Mid-life Cognitive Function$347,159
R01 · FY2021 · AG · contact PI
Improving Risk Estimation in Observational Research on Child Maltreatment: Establishing Methods for the Effective Control of Contamination$80,250
R03 · FY2021 · HD · contact PI
Epigenetic Age Acceleration as a Biomarker of Early Life Adversity and Mid-life Cognitive Function$322,910
R01 · FY2020 · AG · contact PI
Epigenetic Age Acceleration as a Biomarker of Early Life Adversity and Mid-life Cognitive Function$348,487
R01 · FY2019 · AG · contact PI
Epigenetic Age Acceleration as a Biomarker of Early Life Adversity and Mid-life Cognitive Function$357,235
R01 · FY2018 · AG · contact PI